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Rationale: We have developed a novel oxygen adherence monitor that objectively measures 
patient use of long-term oxygen therapy. The monitor attaches to the oxygen source and detects 
whether or not the patient is wearing the nasal cannula.
Objective: The study’s purpose was to validate the monitor’s performance in patients with 
chronic obstructive pulmonary disease during wakefulness and sleep.
Methods: Ten adult males with stable chronic obstructive pulmonary disease (mean ± SD 
FEV1 37.7 ± 14.9% of predicted) on long-term continuous oxygen therapy were tested in a sleep 
laboratory over a 12–13 hour period that included an overnight polysomnogram.
Measurements: The monitor’s measurements were obtained at 4-minute intervals and com-
pared to actual oxygen use determined by review of time-synchronized video recordings.
Main results: The monitor made 1504/1888 (79.7%) correct detections (unprocessed data) 
across all participants: 957/1,118 (85.6%) correct detections during wakefulness and 546/770 
(70.9%) during sleep. All errors were false negatives, ie, the monitor failed to detect that the 
participant was actually wearing the cannula. Application of a majority-vote ﬁ  lter to the raw 
data improved overall detection accuracy to 84.9%.
Conclusions: The results demonstrate the monitor’s ability to objectively measure whether 
or not men with chronic obstructive pulmonary disease are receiving their oxygen treatment. 
The ability to objectively measure oxygen delivery, rather than oxygen expended, may help 
improve the management of patients on long-term oxygen therapy.
Keywords: chronic obstructive pulmonary disease
Long-term oxygen therapy (LTOT) is a well-established treatment for patients with 
oxygen desaturation due to parenchymal lung diseases (NOT 1980; MRC 1981). In 
patients with chronic obstructive pulmonary disease (COPD) and hypoxemia at rest, 
continuous use of LTOT (15 hours/day) improves survival and quality of life, and 
reduces the number of hospitalizations (Criner 2000; Pierson 2000). Unfortunately, 
this therapy is costly, accounting for approximately 30% (US $1.3 billion) of annual 
Medicare expenditures for durable medical equipment (Dunne 2000). It is likely that 
many of these dollars are wasted because studies report that many patients do not 
adhere adequately to this treatment (Howard et al 1992; Granados et al 1997; Avdeev 
et al 1999).
Compounding this problem, current methods used to measure adherence to LTOT 
probably overestimate actual use. Each type of oxygen source used for LTOT requires 
a different method to objectively assess patient adherence to treatment. For the oxygen 
concentrator, average daily use is estimated by recording the concentrator’s hour-meter 
readings (“power on” time) over a known period of time. For oxygen tanks, adherence is 
estimated by knowing the prescribed ﬂ  ow rate and the number of tanks used. For liquid 
oxygen, adherence is calculated by weighing the container, knowing the ﬂ  ow rate, and International Journal of COPD 2008:3(3) 436
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estimating the amount of evaporation and venting from the 
system. All of the above measures are deﬁ  cient and probably 
misleading because: 1) they do not discern whether or not the 
patient is actually inhaling the oxygen, as opposed to merely 
having the oxygen source turned on, ie, oxygen expenditure 
may not reﬂ  ect oxygen delivery to the patient, and 2) they fail 
to provide information regarding the timing of oxygen use 
within the day. The lack of an accurate, objective measure 
of adherence to LTOT prevents the accurate determination 
of the optimal duration of daily treatment. In addition, the 
inability to identify patients with inadequate adherence pre-
vents the development of interventions designed to improve 
adherence and thereby to increase the effectiveness of this 
expensive but life-saving treatment.
We have developed a novel oxygen adherence monitor to 
address the above limitations and objectively document when 
a patient is actually receiving oxygen treatment (Lin et al 
2006). The monitor attaches to the oxygen source and detects 
pressure in the tubing, including the respiratory-related pres-
sure ﬂ  uctuations transmitted from the nares. The monitor is 
designed to detect when the oxygen source is turned on and 
when the patient is actually wearing the nasal cannula and 
receiving treatment. Our monitor performs measurements 
every four minutes over a 25-second duration and, for each 
measurement, identiﬁ  es one of four conditions: source-on/
cannula-on, source-on/cannula-off, source-off/cannula-off, 
and source-off/cannula-on. Periodic measurement, as opposed 
to continuous measurement, was selected to extend battery life 
of the AA battery powered monitor. The design and operating 
characteristics of the device have been previously detailed and 
the device has been validated in patients with COPD under 
controlled conditions during relatively short periods while 
sitting at rest and walking (Lin et al 2006). The purpose of 
the current study was to evaluate the monitor’s performance 
in patients with COPD during wakefulness and sleep over a 
longer period of time and under less controlled conditions. 
Some of the results of these studies have been previously 
reported in the form of an abstract (Lin et al 2005).
Methods
Participant selection
Ten male adults with COPD using continuous LTOT via 
nasal cannula were enrolled (Table 1). The participants were 
recruited from veterans receiving care at the Philadelphia 
Veterans Affairs Medical Center, where men constitute about 
85% of the patient population.
COPD was identiﬁ  ed as a forced expiratory volume in 
one second (FEV1)/forced vital capacity (FVC) 70% and 
an FEV1 80% of predicted without signiﬁ  cant improve-
ment following bronchodilator administration. None of the 
participants had a previous diagnosis of sleep apnea or other 
sleep disorder. The study was approved by the Institutional 
Review Boards at the Philadelphia VAMC and the University 
of Pennsylvania. Written informed consent was obtained 
from all participants.
Oxygen adherence monitor
The oxygen adherence monitor (18 × 10 × 2 cm) was attached 
by a “T” connection to the oxygen tubing near the oxygen 
source (Lin et al 2006). The monitor consists of a pneumatic 
ﬁ  ltering system and an electronic detection system. The 
pneumatic ﬁ  ltering system isolates the ﬂ  uctuations in nasal 
pressure from the oxygen supply pressure. The electronic 
system consists of two pressure transducers, a microprocessor 
used to sample the data coming from the pressure transduc-
ers, a memory storage chip, and a serial port to allow cable 
connection for downloading data to a personal computer. 
The microprocessor is programmed to identify four different 
conditions (source-on/cannula-on, source-on/cannula-off, 
source-off/cannula-off, and source-off/cannula-on), record 
the exact time and date when each condition occurred, and 
tabulate the total time spent in each condition.
Protocol
The participants arrived at the sleep center at 16:00 and 
were administered supplemental oxygen at their prescribed 
ﬂ  ow rate (2–3 L/min) through a nasal cannula with a 50-ft 
length of tubing attached to the wall oxygen supply in their 
bedroom. Oxygen ﬂ  ow rate remained constant throughout 
the protocol. Therefore, the protocol tested two conditions: 
source-on/cannula-off and source-on/cannula-on.
The participants were aware of the purpose of the study 
and were instructed to remove the nasal cannula whenever 
Table 1 Clinical characteristics of the 10 participants
Measure Mean ± SD
Age (yr) 64 ± 7
Height (cm) 174.8 ± 4.3
Weight (kg) 94.3 ± 16.8
FEV1 (L) 1.19 ± 0.43
FEV1 (% predicted) 37.7 ± 14.9
FVC (L) 2.43 ± 0.73
FEV1/FVC (%) 59.6 ± 16.3
Abbreviations: FEV1, forced expiratory volume in one second; FVC, forced vital 
capacity.International Journal of COPD 2008:3(3) 437
Oxygen adherence monitor
they wished during wakefulness. Each participant performed 
an overnight polysomnogram while wearing the oxygen 
cannula. Prior to the start of the polysomnogram, they were 
encouraged to watch TV, read magazines, and walk in their 
bedroom. They were provided dinner between 18:00–19:00 
and then changed into their bedtime clothes. Between 
20:00–21:00, the sleep technologist attached the polysom-
nographic sensors while the participants sat in a chair. The 
participants went to bed at their regular bedtimes, and the 
polysomnograms were recorded using standard techniques 
(AASM 1999).
Two wide-angle infrared cameras were placed in the 
bedroom to determine whether or not the patient was wear-
ing the oxygen cannula. Each camera was placed in an 
opposite corner of the room to obtain the largest viewable 
area. The video images from each camera were fed into a 
single surveillance VCR (Lorex Technology Inc., Markham, 
Ontario, Canada), that multiplexed the images from both 
cameras and time-stamped the frames. White-colored paper 
tags (1 × 2 inches) were placed on the nasal cannula tubing 
at each cheek so that the cannula was clearly visible on the 
video recording. Logs of the participants’ activities were kept 
by the sleep technologists and were used to help interpret the 
images on the videotape.
Throughout the protocol, the subjects wore an ultra-thin 
nasal cannula with 4-foot length tubing securely taped to the 
oxygen cannula to obtain simultaneous, continuous nasal 
pressure recordings. During wakefulness, nasal pressure 
was recorded using a light-weight, battery powered pressure 
recorder (Stardust II, Respironics, Pittsburgh, PA, USA) 
that hung around the neck. During the polysomnogram, the 
ultra-thin nasal cannula was connected to a pressure trans-
ducer (Pro-Tech, Woodinville, WA, USA) with output to the 
polysomnographic computer.
All time-sensitive devices used in the study were time-
synched to the oxygen adherence monitor at the beginning 
of the protocol.
Data analysis
The data from the oxygen adherence monitor were down-
loaded in text format for analysis. The polysomnograms were 
manually scored with the aid of computer software by a certi-
ﬁ  ed polysomnographic technologist using standard guidelines 
(ATS 1989; AASM 1999). All abnormal respiratory events 
were at least 10 seconds in duration. Apneas were deﬁ  ned 
by an absence of airﬂ  ow as evidenced by the nasal pressure 
cannula signal. Hypopneas were deﬁ  ned as a greater than 
50% reduction in a respiratory signal from baseline, or a less 
than 50% reduction in a respiratory signal from baseline that 
was associated with an arousal or an oxygen desaturation of 
at least 3% (AASM 1999).
The monitor’s measurement (cannula “on” vs. cannula 
“off”) from each sampling period was compared to the 
same period of time on the videotape recording. Thirty out 
of the total 1,918 measurements (2%) occurred when the 
participants were out of camera view and were excluded. 
The accuracy of the monitor was assessed by computing the 
percentage of the monitor’s measurements that were correct 
relative to the videotape. The simultaneous, continuous nasal 
pressure recordings were reviewed to evaluate possible expla-
nations for any discrepancies between videotape and monitor, 
eg, the videotape showing that the cannula was “on”, but the 
monitor detecting the event as cannula “off  ”.
Recognizing that the overall error contribution during 
wakefulness and sleep was due to random false negatives, a 
post-processing majority-vote ﬁ  lter was applied to the data 
in an attempt to improve the accuracy of the monitor. The 
majority-vote ﬁ  lter, sometimes referred to as a majority logi-
cal ﬁ  lter, is a standard digital analysis technique commonly 
used to reduce noise in graphical data (Ting and Prasada 
1980). The technique involves taking an odd-number of 
contiguous sample points, each of which is designated as a 
“1” or a “0”, counting up which value is more frequent (ie, 
are there more “1’s” or more “0’s”?), and then assigning 
the more frequent value to the center point of the collection. 
Thus, the center point becomes a “1” if a majority of the data 
points are “1’s.” This algorithm is then applied to all possible 
same-size sample point collections in the data set.
In the present application, the majority-vote ﬁ  lter was 
applied to each sequence of ﬁ  ve successive sample points with 
the “cannula-on” state designated as “1”, and the “cannula-off” 
state as “0”. Thus, one can imagine the ﬁ  lter “moving along” 
the time sequence of data points, taking ﬁ  ve at a time, deter-
mining the majority for those ﬁ  ve, and then shifting along 
one time unit to process the next (overlapping) group of ﬁ  ve 
points. If the majority of measurements (3) within a par-
ticular sequence indicated that the participant was wearing 
the cannula, then the decision algorithm stipulated that the 
cannula was “on”. If the majority of measurements indicated 
that the patient was not wearing the cannula, then the decision 
algorithm stipulated that the cannula was “off”.
Results
Each participant was monitored for at least 12 hrs (mean ± 
SD = 12.9 ± 0.6). Time during wakefulness prior to the start 
of the polysomnogram ranged from 3 to 6 hrs (5.0 ± 0.8) and International Journal of COPD 2008:3(3) 438
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polysomnogram duration ranged from 6 to 9 hrs (7.9 ± 0.8). 
The polysomnographic results are presented in Table 2.
The mean total sleep time was 5.4 ± 1.8 hrs and the 
mean sleep efficiency (total sleep time/recording time) 
was 68.3% ± 23.5%. The mean apnea-hypopnea index was 
18.5 ± 19.2 events/hr (range 2.0 to 63.1). All 8 patients 
with an apnea-hypopnea index above 5 events/hr had 
obstructive sleep apnea, and there was no evidence of 
Cheyne-Stokes respiratory pattern. The apnea-hypopnea 
index was 5 events/hr in 2 participants, between 5 
and 14.9 events/hr in 4 participants, between 15 and 29.9 
events/hr in 2 participants, and 30 events/hr or greater in 2 
participants. Minimum oxygen saturation was 86.4% ± 10.5%; 
and only 0.6% ± 1.1% of the recording time was spent below 
90% oxygen saturation.
Combining all data from the 10 participants, there were a 
total of 1,888 measurements (1,118 during wakefulness and 770 
during sleep) (Table 3). The oxygen adherence monitor detected 
the correct condition in 1,504 measurements (unprocessed 
data), yielding an overall raw detection accuracy of 79.7%. 
The monitor made 957/1,118 (85.6%) correct detections during 
wakefulness and 546/770 (70.9%) during sleep.
The monitor correctly detected all 47 measurements 
that occurred when the participants were not wearing the 
cannula, conﬁ  rming the 100% speciﬁ  city described in 
our previous validation study (Lin et al 2006). All errors 
(161 during wakefulness and 223 during sleep) were false 
negatives: ie, situations in which the monitor failed to 
detect that the participant was actually wearing the cannula. 
Prior to the polysomnogram recording, errors were more 
common during rest than during activities such as eating, 
talking, and dressing. Errors were more common during 
REM compared to NREM sleep. Overall, 73.3% of the 
measurements were correct during NREM sleep whereas 
only 57.3% of the measurements obtained in REM sleep 
were correct.
Evaluating each individual’s results, the mean percentage 
of accurate measurements over the entire recording period 
was 79.3 ± 17.1%. Results varied widely across participants, 
particularly during NREM and REM sleep (Table 3). 
Mean detection accuracy was 85.5 ± 9.0% in wakefulness, 
69.5% ± 34.6% in NREM sleep, and 63.6 ± 36.8% in REM 
sleep. Individual detection accuracy in wakefulness was 
below 80% in 2 of the participants. The monitor’s detection 
accuracy was less than 80% in 5 of 10 participants during 
NREM and REM sleep. Participants with the highest number 
of detection errors were observed to have more frequent 
episodes of diminished nasal pressure ﬂ  uctuations on the 
simultaneous nasal pressure recording. On review of the false 
negative detection errors, 94% could be explained by this 
phenomenon. The remaining 6% of detection errors could 
not be explained after reviewing the nasal pressure signals. 
That is, a detection error occurred when the participant was 
observed on the video recording to be wearing the cannula 
and had clear nasal pressure signals on the simultaneous 
nasal pressure recording during the monitor’s measurement 
period.
There were no ﬁ  ndings on routine history or physical 
exam that identiﬁ  ed those individuals in whom there was 
lower detection accuracy during wakefulness. Figure 1 
shows the relationship between the percentage of correct 
measurements during sleep and the apnea-hypopnea index 
in all participants.
The relationship across all participants was not signiﬁ  -
cant (R2 = 0.08, p  0.05). However, when the two partici-
pants (participants 8 and 9) with a relatively low AHI and 
low percentage of correct measurements during sleep were 
removed from the analysis, a signiﬁ  cant negative correla-
tion was present in the remaining 8 participants (R2 = 0.93, 
p  0.001). In contrast to the remaining eight participants, 
the 2 participants with the unusual results showed a sig-
niﬁ  cant amount of relatively shallow respiratory-related 
pressure ﬂ  uctuations on the simultaneous nasal pressure 
recording during sleep, even when apneas and hypopneas 
were absent.
Approximately half of the monitor’s measurements that 
occurred in association with an apnea or hypopnea resulted 
in a detection error. Those apneas and hypopneas that did 
not extend over the entire measurement period often allowed 
enough time for the monitor to detect at least 2 respiratory-
related nasal pressure cycles, the minimum number required 
Table 2 Results of polysomnogram (PSG) recordings
Measure Mean ± SD
Total time monitored before PSG (hr) 5.0 ± 0.8
Total time monitored during PSG (hr) 7.9 ± 0.8
Total sleep time (hr) 5.4 ± 1.8
Time in NREM sleep (hr) 4.5 ± 1.8
Time in REM sleep (min) 47.3 ± 23.4
Sleep efﬁ  ciency (%) 68.3 ± 23.5
Apnea/hypopnea index (events/hr) 18.5 ± 19.2
Mean O2 saturation (%) 97.5 ± 0.8
Minimum O2 saturation (%) 86.4 ± 10.5
Time O2 saturation 90% (%)a 0.6 ± 1.1
Note: aPercent of total sleep time that oxygen saturation was 90%.International Journal of COPD 2008:3(3) 439
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Figure 1 Percent of correct measurements with the oxygen adherence monitor versus apnea-hypopnea index (AHI) during sleep in all ten participants. The square markers 
represent the two participants in whom there were a high number of incorrect measurements despite a relatively low AHI. Regression lines are shown for data including all 
participants (solid line, R2 = 0.083) and data excluding two of the subjects (dashed line, excluding square markers, R2 = 0.93, p  0.001).
during a measurement to designate the “cannula-on” 
condition (Figure 2).
The majority-vote ﬁ  lter was applied to measurements 
obtained prior to and during the polysomnogram, the lat-
ter including both wakefulness and sleep periods due to 
the frequent transitions between the two states during 
the polysomnogram recordings. The majority-vote ﬁ  lter 
improved the monitor’s overall detection accuracy, over the 
entire recording period, to 84.9% (Table 4).
Without the ﬁ  lter, ie, unprocessed data, the mean accuracy 
across participants was 86.2 ± 9.8% prior to the polysomno-
gram and 75.2 ± 22.5% during the polysomnogram. When 
Table 3 Detection accuracy of the monitor during wakefulness and sleep
Participant Wakefulness NREM sleep REM sleep
# Total # Correct % Correct #  Total # Correct % Correct # Total # Correct % Correct
1 97 88 90.7 94 87 92.6 13 10 76.9
2 119 114 95.8 65 62 95.4 16 15 93.8
3 137 119 86.9 58 22 37.9 11 2 18.2
4 80 65 81.3 87 86 98.9 14 14 100
5 90 85 94.4 102 81 79.4 5 4 80.0
6 165 142 86.1 19 18 94.7 1 1 100
7 115 75 65.2 39 1 2.6 24 5 20.8
8 107 83 77.6 58 15 25.9 9 0 0
9 89 73 82.0 88 65 73.9 12 8 66.7
10 119 113 95.0 50 47 94.0 5 4 80.0
Total 1118 957 85.6 660 484 73.3 110 63 57.3
Mean 85.5 69.5 63.6
SD 9.0 34.6 36.8
Notes: Total # = total number of samples; # Correct = number of samples in which the monitor determined the correct conditions (ie, cannula-on and cannula-off); % Correct = 
percentage of samples in which the monitor determined the correct conditions.International Journal of COPD 2008:3(3) 440
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Figure 2 Nasal pressure recordings during sleep in two participants who were wearing nasal cannula. The recording in the upper panel reveals repetitive apneas in an individual 
during NREM sleep. The prolonged period of absent and markedly attenuated nasal pressure signal in the recording in the lower panel occurred in another participant during 
REM sleep. The solid bars indicate the time that the oxygen adherence monitor obtained one of its 25 second samples. The sample in the upper panel occurred near the end 
of an apnea; and there were a sufﬁ  cient number of respiratory-related pressure ﬂ  uctuations for the monitor to correctly detect that the participant was wearing the cannula. 
In the lower panel, the pressure ﬂ  uctuations during the sampling period were of insufﬁ  cient amplitude; and the monitor incorrectly determined that the participant was not 
wearing the cannula.
Table 4 Effect of applying a majority-vote ﬁ  lter on the percentage of the monitor’s correct determinations*
Participant Raw data Majority vote ﬁ  lter
Before PSG During PSG Total Before PSG During PSG Total
1 89.3 91.7 90.7 96.3 99.2 98.0
2 94.5 96.3 95.5 96.6 99.1 98.0
3 91.8 57.1 69.4 100 57.3 72.3
4 85.7 93.6 91.2 100 100 100
5 94.8 80.8 86.3 98.7 100 99.5
6 82.0 89.5 87 91.5 100 97.2
7 65.2 38.6 45.5 52.3 36.2 40.2
8 76.3 39.4 56.3 88.5 40.2 62.4
9 84.9 72.4 77.2 85.9 79.8 82.2
10 97.1 92.4 94.3 98.5 100 99.4
Mean 86.2 75.2 79.3 90.8 81.2 84.9
SD 9.8 22.5 17.1 14.4 26.5 20.6
Notes: *Correct determinations = (number of samples correctly identiﬁ  ed as cannula-on or cannula-off/total number of samples).
the majority-vote ﬁ  lter was applied to these data, the mean 
detection accuracy rose to 90.8 ± 14.4% prior to the poly-
somnogram and 81.2 ± 26.5% during the polysomnogram. 
Application of the ﬁ  lter improved detection accuracy in 9 of 
the 10 participants before the polysomnogram and in 8 of the 
10 participants during the polysomnogram.
Discussion
The results demonstrate the ability of our oxygen adher-
ence monitor to objectively measure whether or not 
patients with COPD are receiving their oxygen treatment. 
The monitor’s accuracy in detecting whether or not the 
participants were wearing the nasal cannula, without International Journal of COPD 2008:3(3) 441
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post-processing, was 79.3% ± 17.1%. Mean detection 
accuracy was 85.5% ± 9.0% in wakefulness, 69.5 ± 34.6% 
in NREM sleep, and 63.6% ± 36.8% in REM sleep. All errors 
were due to the monitor failing to detect that the participant 
was actually wearing the cannula. In 8 of the 10 subjects, 
the percentage of detection errors during sleep appeared to 
be directly related to the apnea-hypopnea index. The overall 
detection accuracy of 79.7% using the raw data improved to 
84.9% with application of a post-processing majority-vote 
ﬁ  lter.
The results extend our previous study by testing the 
monitor’s performance during different activities of daily 
living and sleep in patients with COPD (Lin et al 2006). In 
our previous study, we used direct observation to validate the 
monitor’s performance in patients with COPD. In contrast 
to the current study, that previous study consisted of a 
relatively brief protocol, lasting about 1 hour, during periods 
of sitting and walking that were precisely timed so that the 
transitions between the different conditions did not occur 
when the monitor was making a measurement. In addition, 
the previous study was performed using nasal cannula 
with a 6-foot length of tubing. Under those circumstances, 
the monitor had an overall 86% sensitivity (ie, correctly 
detecting that the cannula were on) and 100% speciﬁ  city (ie 
correctly detecting that the cannula were off). The current 
study tested the monitor’s performance over a longer period 
of time during both wakefulness and sleep using 50-ft 
length nasal cannula, and under less controlled conditions 
than our previous study (Lin et al 2006). The subjects were 
free to perform their usual activities of daily living during 
wakefulness. The results of the current study indicate that 
the monitor is able to detect the presence or absence of 
respiratory-related pressure ﬂ  uctuations at the nares during 
wakefulness and sleep even when positioned at the end a 
50-ft. length of tubing, the standard length used at home by 
patients on LTOT.
In the current study, patients were observed simultaneously 
by three methods: oxygen adherence monitor, video-record-
ing, and continuous nasal pressure recordings. The video-
recording served as our “direct observation” to document 
whether or not the participant was wearing the cannula. These 
observations allowed us to determine the accuracy of the oxy-
gen adherence monitor. The nasal pressure recordings allowed 
us to evaluate discrepancies between the oxygen monitor and 
the video-recording, ie, to differentiate between the technical 
(ability of the monitor to sense the pressure ﬂ  uctuations at the 
nares) and methodological (actual presence of signiﬁ  cant nasal 
pressure ﬂ  uctuations) causes of the discrepancies.
The technical assessment relates to the monitor’s ability to 
detect respiratory-related pressure ﬂ  uctuations in the cannula 
supply line. These small pressure ﬂ  uctuations from the nares 
are superimposed on a much larger oxygen supply pressure 
delivered at the proximal end of a long tube, and then detected 
through a microprocessor-controlled electropneumatic 
device. In principle, limitations in the design, construction, 
and use of the monitor might result in inaccurate detection 
of breathing. For example, if inspection of the nasal pres-
sure recording showed that there was a good nasal pressure 
signal, but the monitor did not detect this breathing signal, 
then we would conclude that there was a technical limitation.
A review of the continuous nasal pressure recordings at the 
time of almost all incorrect measurements showed that the 
pressure signal during these sampling periods were, in fact, 
very shallow or virtually ﬂ  at, indicating that the monitor’s 
inability to correctly detect when the cannula was “on” was 
due to the method used to assess adherence rather than the 
monitor’s technical performance.
Even if the monitor works perfectly from a technical 
standpoint, it may still make incorrect observations in sub-
jects who do not breathe normally through the nose. We 
deﬁ  ned “oxygen use” in terms of the presence of respiratory-
related pressure ﬂ  uctuations at the nares. We recognize the 
possibility that these pressure ﬂ  uctuations may be absent even 
though the nasal cannula are placed correctly in the nares. 
Pharyngeal airway closure during sleep, mouth breathing, and 
nasal airway obstruction might result in little or no respira-
tory-related pressure variations at the nares. For example, a 
shift from nasal to oral breathing might be associated with 
closure of the retropalatal oropharynx, damping transmis-
sion of airway pressure into the nasal passage (Thurnheer 
et al 2001). Under such circumstances, our device might not 
sense nasal breathing even when the subject was wearing the 
cannula and would incorrectly indicate that the subject was 
not adhering to treatment. This appears to be the explanation 
for many of the detection errors during sleep. Measurement 
errors tended to be more common in participants with a 
higher apnea-hypopnea index, and apneas and hypopneas are 
associated with absent or relatively low respiratory-related 
nasal pressure ﬂ  uctuations. Since the monitor depends on 
the presence of respiratory-related ﬂ  uctuations to deter-
mine if the patient is using the cannula, the lack of these 
ﬂ  uctuations explains why the monitor incorrectly indicated 
that the cannula was not being worn. Increasing the length 
of the sample period or the sampling frequency might help 
reduce the monitor’s detection errors in the presence of sleep 
disordered breathing.International Journal of COPD 2008:3(3) 442
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Six percent of detection errors could not be explained 
after reviewing the nasal pressure signals. That is, a detection 
error occurred when the patient was directly observed to 
be wearing the cannula and the continuous nasal pressure 
recording showed adequate respiratory-related pressure 
ﬂ  uctuations. The most likely explanation is that the continu-
ous nasal pressure recordings during those periods may not 
have fully represented the signals that were analyzed by the 
monitor. For example, the oxygen delivery tube could have 
been slightly compressed during a measurement but the nasal 
pressure recording tube was undisturbed. The monitor’s 
pneumatic ﬁ  ltering system is sensitive to sharp pressure 
increases that cause the incoming pressure signal to be out 
of detection range. In these cases, the monitor detects that 
the patient is not wearing the cannula. A situation in which 
this might occur could be when the patient is turning in his 
sleep and partially resting on the oxygen delivery tube.
In summary, the results further validate the use of a novel 
monitor to objectively document patient adherence to LTOT. 
The monitor was most accurate in detecting when participants 
were not wearing the cannula, yielding 100% speciﬁ  city. 
Excellent results were also obtained when participants were 
awake and performing daily activities. The most difﬁ  cult 
monitoring situation was observed during sleep, and results 
indicate that accuracy may be reduced in participants who are 
mouth breathers and/or have frequent apneas and hypopneas. 
Processing the data with a majority-vote ﬁ  lter improved 
detection accuracy. The monitor’s ability to objectively 
measure oxygen delivery, rather than oxygen expended, and 
determine daily patterns of oxygen use will provide valuable 
information that may lead to new management strategies 
designed to improve patient adherence to LTOT.
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